Clinical Trials Browser

OTHER × Triple Negative Breast Neoplasms × Immunotherapy, Adoptive × Clear all

NCT04609215 2022-04-20

ImmunoBreast - A Phase Ib Study

Phase 1/2 Unknown

Breast Neoplasms, Triple Negative Breast Neoplasms